| Grant W Moehring, MD | |
|
725 American Ave, Suite 5, Waukesha, WI 53188-5031 | |
| (262) 928-2475 | |
| (262) 928-5697 |
| Full Name | Grant W Moehring |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 25 Years |
| Location | 725 American Ave, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770560443 | NPI | - | NPPES |
| 34105200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 42479-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Waukesha Memorial Hospital | Waukesha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Medical Associates Llp | 0648242065 | 15 |
News Archive
The Food and Drug Administration (FDA) in the United States has warned doctors about the dangers of a drug used to treat pain in cancer sufferers.
Noting Bill Gates, co-chair of the Bill & Melinda Gates Foundation, released his annual letter and report on Wednesday, Eric Porterfield, director of global health communications at the United Nations Foundation, writes in the United Nations Foundation Blog, "The report is an important reminder that the role of measurement and evaluation is a critical component in addressing global challenges effectively."
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 7 days ago
| Entity Name | Emergency Medical Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861483190 PECOS PAC ID: 0648242065 Enrollment ID: O20040806000968 |
News Archive
The Food and Drug Administration (FDA) in the United States has warned doctors about the dangers of a drug used to treat pain in cancer sufferers.
Noting Bill Gates, co-chair of the Bill & Melinda Gates Foundation, released his annual letter and report on Wednesday, Eric Porterfield, director of global health communications at the United Nations Foundation, writes in the United Nations Foundation Blog, "The report is an important reminder that the role of measurement and evaluation is a critical component in addressing global challenges effectively."
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 7 days ago
| Entity Name | Lake Country Emergency Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720060585 PECOS PAC ID: 4385607555 Enrollment ID: O20041109000212 |
News Archive
The Food and Drug Administration (FDA) in the United States has warned doctors about the dangers of a drug used to treat pain in cancer sufferers.
Noting Bill Gates, co-chair of the Bill & Melinda Gates Foundation, released his annual letter and report on Wednesday, Eric Porterfield, director of global health communications at the United Nations Foundation, writes in the United Nations Foundation Blog, "The report is an important reminder that the role of measurement and evaluation is a critical component in addressing global challenges effectively."
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grant W Moehring, MD 6400 Industrial Loop, Greendale, WI 53129-2452 Ph: (414) 423-4100 | Grant W Moehring, MD 725 American Ave, Suite 5, Waukesha, WI 53188-5031 Ph: (262) 928-2475 |
News Archive
The Food and Drug Administration (FDA) in the United States has warned doctors about the dangers of a drug used to treat pain in cancer sufferers.
Noting Bill Gates, co-chair of the Bill & Melinda Gates Foundation, released his annual letter and report on Wednesday, Eric Porterfield, director of global health communications at the United Nations Foundation, writes in the United Nations Foundation Blog, "The report is an important reminder that the role of measurement and evaluation is a critical component in addressing global challenges effectively."
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 7 days ago
Steven K Kulick, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Dr. Jennifer Quick Grieve, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 | |
Keith L Mausner, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Dr. James Mateer, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Qurisha Monique Boyd, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2411 Springdale Rd Apt 5b, Waukesha, WI 53186 Phone: 262-888-2305 | |
Timothy J Helz, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Brian L Huckstorf, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 |